nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acquired TTP: ADAMTS13 meets the immune system
|
Verbij, Fabian C. |
|
2014 |
|
6 |
p. 227-234 8 p. |
artikel |
2 |
Acute myeloid leukemia with mutated nucleophosmin (NPM1): Any hope for a targeted therapy?
|
Falini, Brunangelo |
|
2011 |
|
6 |
p. 247-254 8 p. |
artikel |
3 |
Advances in stem cell mobilization
|
Motabi, Ibraheem H. |
|
2012 |
|
6 |
p. 267-278 12 p. |
artikel |
4 |
Allogeneic hematopoietic cell transplantation for MDS: For whom, when and how?
|
Gyurkocza, Boglarka |
|
2012 |
|
6 |
p. 247-254 8 p. |
artikel |
5 |
Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach
|
Lodewyck, Tom |
|
2008 |
|
6 |
p. 293-302 10 p. |
artikel |
6 |
Anaemia of prematurity: Pathophysiology and treatment
|
Strauss, Ronald G. |
|
2010 |
|
6 |
p. 221-225 5 p. |
artikel |
7 |
Atrial fibrillation and coagulation: Who and when?
|
Fitzmaurice, David |
|
2009 |
|
6 |
p. 241-244 4 p. |
artikel |
8 |
Beta thalassemia in 31,734 cases with HBB gene mutations: Pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East
|
Mahdieh, Nejat |
|
2016 |
|
6 |
p. 493-508 16 p. |
artikel |
9 |
Beyond the HLA typing age: Genetic polymorphisms predicting transplant outcome
|
Dickinson, Anne M. |
|
2005 |
|
6 |
p. 333-340 8 p. |
artikel |
10 |
Biosimilars: A cure to the U.S. health care cost conundrum?
|
Hirsch, Bradford R. |
|
2014 |
|
6 |
p. 263-268 6 p. |
artikel |
11 |
Bleeding and thrombotic complications of kidney disease
|
Pavord, Sue |
|
2011 |
|
6 |
p. 271-278 8 p. |
artikel |
12 |
Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review
|
Russ, Atlantis |
|
2018 |
|
6 |
p. 480-489 |
artikel |
13 |
Blood and marrow transplantation for sickle cell disease: Is less more?
|
Bolaños-Meade, Javier |
|
2014 |
|
6 |
p. 243-248 6 p. |
artikel |
14 |
Blood coagulation factor XIII and factor XIII deficiency
|
Dorgalaleh, Akbar |
|
2016 |
|
6 |
p. 461-475 15 p. |
artikel |
15 |
Clinical approach to diffuse large B cell lymphoma
|
Caimi, Paolo F. |
|
2016 |
|
6 |
p. 477-491 15 p. |
artikel |
16 |
CNS prophylaxis in lymphoma: Who to target and what therapy to use
|
Hill, Quentin A. |
|
2006 |
|
6 |
p. 319-332 14 p. |
artikel |
17 |
Contents
|
|
|
2018 |
|
6 |
p. iii |
artikel |
18 |
Corrigendum to “Von Willebrand factor and ADAMTS13 in arterial thrombosis: A systematic review and meta-analysis” [Blood Rev 28 (2014) 167–178]
|
Sonneveld, Michelle A.H. |
|
2014 |
|
6 |
p. 281-282 2 p. |
artikel |
19 |
Could stem cells be the future therapy for sepsis?
|
Kingsley, S. Manoj Kumar |
|
2016 |
|
6 |
p. 439-452 14 p. |
artikel |
20 |
Current status and trends in the diagnostics of AML and MDS
|
Shumilov, Evgenii |
|
2018 |
|
6 |
p. 508-519 |
artikel |
21 |
De novo thrombotic microangiopathy after non-renal solid organ transplantation
|
Verbiest, Annelies |
|
2014 |
|
6 |
p. 269-279 11 p. |
artikel |
22 |
Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies
|
Scott, Linda M. |
|
2015 |
|
6 |
p. 405-415 11 p. |
artikel |
23 |
Diagnosis and management of the antiphospholipid syndrome
|
Chaturvedi, Shruti |
|
2017 |
|
6 |
p. 406-417 12 p. |
artikel |
24 |
Diagnosis of megaloblastic anaemias
|
Wickramasinghe, S.N. |
|
2006 |
|
6 |
p. 299-318 20 p. |
artikel |
25 |
Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention
|
Zhou, Fuling |
|
2013 |
|
6 |
p. 261-267 7 p. |
artikel |
26 |
Editorial Board
|
|
|
2009 |
|
6 |
p. i- 1 p. |
artikel |
27 |
Editorial Board
|
|
|
2018 |
|
6 |
p. i |
artikel |
28 |
Eryptosis in health and disease: A paradigm shift towards understanding the (patho)physiological implications of programmed cell death of erythrocytes
|
Qadri, Syed M. |
|
2017 |
|
6 |
p. 349-361 13 p. |
artikel |
29 |
Fibrinogen and cardiovascular disease: Genetics and biomarkers
|
Tousoulis, Dimitris |
|
2011 |
|
6 |
p. 239-245 7 p. |
artikel |
30 |
From evidence to clinical practice in blood and marrow transplantation
|
Khera, Nandita |
|
2015 |
|
6 |
p. 351-357 7 p. |
artikel |
31 |
Frontline treatment of multiple myeloma in elderly patients
|
Moreau, Philippe |
|
2008 |
|
6 |
p. 303-309 7 p. |
artikel |
32 |
Genetic causes of erythrocytosis and the oxygen-sensing pathway
|
Lee, Frank S. |
|
2008 |
|
6 |
p. 321-332 12 p. |
artikel |
33 |
Haemostatic problems in acute promyelocytic leukaemia
|
Arbuthnot, Carolina |
|
2006 |
|
6 |
p. 289-297 9 p. |
artikel |
34 |
Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment
|
Krakow, Elizabeth F. |
|
2014 |
|
6 |
p. 249-261 13 p. |
artikel |
35 |
Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review
|
Hayden, Anna |
|
2016 |
|
6 |
p. 411-420 10 p. |
artikel |
36 |
Hemophilic arthropathy in patients with von Willebrand disease
|
van Galen, K.P.M. |
|
2012 |
|
6 |
p. 261-266 6 p. |
artikel |
37 |
Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment
|
Shovlin, Claire L. |
|
2010 |
|
6 |
p. 203-219 17 p. |
artikel |
38 |
How Will Haematologists Use Proteomics?
|
Unwin, Richard D. |
|
2007 |
|
6 |
p. 315-326 12 p. |
artikel |
39 |
Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications
|
Regenboog, Martine |
|
2016 |
|
6 |
p. 431-437 7 p. |
artikel |
40 |
Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation
|
Blair, Allison |
|
2005 |
|
6 |
p. 289-300 12 p. |
artikel |
41 |
Improving outcomes in umbilical cord blood transplantation: State of the art
|
Cutler, Corey |
|
2012 |
|
6 |
p. 241-246 6 p. |
artikel |
42 |
Induction therapy for elderly patients with acute myeloid leukemia
|
Martin, Mike G. |
|
2008 |
|
6 |
p. 311-320 10 p. |
artikel |
43 |
Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies
|
Teh, Benjamin W. |
|
2018 |
|
6 |
p. 499-507 |
artikel |
44 |
Iron and transfusion medicine
|
Waldvogel-Abramovski, Sophie |
|
2013 |
|
6 |
p. 289-295 7 p. |
artikel |
45 |
Iron toxicity – Its effect on the bone marrow
|
Isidori, Alessandro |
|
2018 |
|
6 |
p. 473-479 |
artikel |
46 |
Lyse or not to lyse: Clinical significance of red blood cell autoantibodies
|
Meulenbroek, Elisabeth M. |
|
2015 |
|
6 |
p. 369-376 8 p. |
artikel |
47 |
Management of indolent lymphoma: Where are we now and where are we going
|
Lunning, Matthew A. |
|
2012 |
|
6 |
p. 279-288 10 p. |
artikel |
48 |
Management of multiple myeloma: The changing landscape
|
Reece, Donna E. |
|
2007 |
|
6 |
p. 301-314 14 p. |
artikel |
49 |
Management of sickle cell disease from childhood through adulthood
|
Kanter, Julie |
|
2013 |
|
6 |
p. 279-287 9 p. |
artikel |
50 |
Managing critically Ill hematology patients: Time to think differently
|
Azoulay, Elie |
|
2015 |
|
6 |
p. 359-367 9 p. |
artikel |
51 |
Managing resistance in chronic myeloid leukemia
|
Roychowdhury, Sameek |
|
2011 |
|
6 |
p. 279-290 12 p. |
artikel |
52 |
Milestones in umbilical cord blood transplantation
|
Gluckman, E. |
|
2011 |
|
6 |
p. 255-259 5 p. |
artikel |
53 |
Myelodysplasic syndromes: A comprehensive review
|
Catenacci, Daniel V.T. |
|
2005 |
|
6 |
p. 301-319 19 p. |
artikel |
54 |
Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly
|
Betsch, A. |
|
2018 |
|
6 |
p. 490-498 |
artikel |
55 |
Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction
|
Gardiner, Elizabeth E. |
|
2012 |
|
6 |
p. 255-259 5 p. |
artikel |
56 |
Notch signaling in hematopoietic cell transplantation and T cell alloimmunity
|
Ebens, Christen L. |
|
2013 |
|
6 |
p. 269-277 9 p. |
artikel |
57 |
Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
|
Jona, Adam |
|
2010 |
|
6 |
p. 233-238 6 p. |
artikel |
58 |
Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma
|
Adams, Hugo J.A. |
|
2015 |
|
6 |
p. 417-425 9 p. |
artikel |
59 |
Palliative care and hematologic oncology: The promise of collaboration
|
Epstein, Andrew S. |
|
2012 |
|
6 |
p. 233-239 7 p. |
artikel |
60 |
Pathways towards indolent B-cell lymphoma — Etiology and therapeutic strategies
|
van den Brand, Michiel |
|
2017 |
|
6 |
p. 426-435 10 p. |
artikel |
61 |
Plasma contact factors as therapeutic targets
|
Tillman, Benjamin F. |
|
2018 |
|
6 |
p. 433-448 |
artikel |
62 |
Platelet populations and priming in hematological diseases
|
Baaten, Constance C.F.M.J. |
|
2017 |
|
6 |
p. 389-399 11 p. |
artikel |
63 |
Platelets and physics: How platelets “feel” and respond to their mechanical microenvironment
|
Qiu, Yongzhi |
|
2015 |
|
6 |
p. 377-386 10 p. |
artikel |
64 |
POEMS syndrome
|
Dispenzieri, Angela |
|
2007 |
|
6 |
p. 285-299 15 p. |
artikel |
65 |
Prophylactic therapy in haemophilia
|
Ljung, Rolf |
|
2009 |
|
6 |
p. 267-274 8 p. |
artikel |
66 |
Recipient and donor cells in the graft-versus-solid tumor effect: It takes two to tango
|
Dierckx de Casterlé, Isabelle |
|
2018 |
|
6 |
p. 449-456 |
artikel |
67 |
Renal complications in transfusion-dependent beta thalassaemia
|
Ponticelli, Claudio |
|
2010 |
|
6 |
p. 239-244 6 p. |
artikel |
68 |
Resuscitation and transfusion principles for traumatic hemorrhagic shock
|
Spinella, Philip C. |
|
2009 |
|
6 |
p. 231-240 10 p. |
artikel |
69 |
Subject Index
|
|
|
2005 |
|
6 |
p. IV-X nvt p. |
artikel |
70 |
Subject Index
|
|
|
2010 |
|
6 |
p. V-IX nvt p. |
artikel |
71 |
Subject Index: Volume 23 (2009)
|
|
|
2009 |
|
6 |
p. V-XII nvt p. |
artikel |
72 |
Subject Index: Volume 20 (2006)
|
|
|
2006 |
|
6 |
p. IV-XI nvt p. |
artikel |
73 |
Subject Index: Volume 22 (2008)
|
|
|
2008 |
|
6 |
p. V-XII nvt p. |
artikel |
74 |
Targeting the ubiquitin proteasome system in haematological malignancies
|
Crawford, Lisa J. |
|
2013 |
|
6 |
p. 297-304 8 p. |
artikel |
75 |
T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers
|
Drobna, Monika |
|
2018 |
|
6 |
p. 457-472 |
artikel |
76 |
Telomere biology in hematopoiesis and stem cell transplantation
|
Gadalla, Shahinaz M. |
|
2011 |
|
6 |
p. 261-269 9 p. |
artikel |
77 |
The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates
|
Kaiser-Guignard, Julie |
|
2014 |
|
6 |
p. 235-241 7 p. |
artikel |
78 |
The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels
|
Barnard, Sunelle A. |
|
2016 |
|
6 |
p. 421-429 9 p. |
artikel |
79 |
The incidental monoclonal protein: Current approach to management of monoclonal gammopathy of undetermined significance (MGUS)
|
Madan, Sumit |
|
2009 |
|
6 |
p. 257-265 9 p. |
artikel |
80 |
The post-PE syndrome: a new concept for chronic complications of pulmonary embolism
|
Klok, F.A. |
|
2014 |
|
6 |
p. 221-226 6 p. |
artikel |
81 |
Therapeutic potential of embryonic stem cells
|
Lerou, Paul H. |
|
2005 |
|
6 |
p. 321-331 11 p. |
artikel |
82 |
Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity
|
Boshuizen, M. |
|
2017 |
|
6 |
p. 400-405 6 p. |
artikel |
83 |
The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances
|
Barbui, T. |
|
2016 |
|
6 |
p. 453-459 7 p. |
artikel |
84 |
The skin as a window to the blood: Cutaneous manifestations of myeloid malignancies
|
Li, Alvin W. |
|
2017 |
|
6 |
p. 370-388 19 p. |
artikel |
85 |
The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60years
|
Wall, Sarah A. |
|
2017 |
|
6 |
p. 362-369 8 p. |
artikel |
86 |
Thrombohemorrhagic complications of myeloproliferative disorders
|
Papadakis, Emmanouil |
|
2010 |
|
6 |
p. 227-232 6 p. |
artikel |
87 |
Transfusion-related acute lung injury (TRALI): Current concepts and misconceptions
|
Silliman, Christopher C. |
|
2009 |
|
6 |
p. 245-255 11 p. |
artikel |
88 |
Transfusion-related immunomodulation (TRIM): An update
|
Vamvakas, Eleftherios C. |
|
2007 |
|
6 |
p. 327-348 22 p. |
artikel |
89 |
Treatment for patients with newly diagnosed multiple myeloma in 2015
|
Mateos, María-Victoria |
|
2015 |
|
6 |
p. 387-403 17 p. |
artikel |
90 |
Treatment of acute myeloid leukemia in the next decade – Towards real-time functional testing and personalized medicine
|
Lam, Stephen Sze-Yuen |
|
2017 |
|
6 |
p. 418-425 8 p. |
artikel |
91 |
Tumor microenvironment and drug resistance in hematologic malignancies
|
Li, Zhi-Wei |
|
2006 |
|
6 |
p. 333-342 10 p. |
artikel |
92 |
Volume and Author Contents
|
|
|
2005 |
|
6 |
p. I-III nvt p. |
artikel |
93 |
Volume Contents and Author Index
|
|
|
2013 |
|
6 |
p. I-IV nvt p. |
artikel |
94 |
Volume Contents and Author Index
|
|
|
2008 |
|
6 |
p. I-IV nvt p. |
artikel |
95 |
Volume Contents and Author Index
|
|
|
2010 |
|
6 |
p. I-IV nvt p. |
artikel |
96 |
Volume Contents and Author Index
|
|
|
2009 |
|
6 |
p. I-IV nvt p. |
artikel |
97 |
Volume Contents and Author Index
|
|
|
2006 |
|
6 |
p. I-III nvt p. |
artikel |
98 |
Volume Contents and Author Index
|
|
|
2011 |
|
6 |
p. I-IV nvt p. |
artikel |